BrightPath Biotherapeutics Co., Ltd.
Cancer Treatment Pharmaceutical Development
Brightpath is a drug discovery venture specializing in the development of novel cellular and antibody medicines for cancer treatment, possessing a new allogeneic CAR-T platform created from iPS cells and a dual-specificity antibody production technology.
